Mazdutide demonstrates significant weight loss efficacy and multiple metabolic benefits
The 48-week outcomes from a Phase 2 clinical study of higher dose (9mg) mazdutide in Chinese subjects with obesity have demonstrated...
Mazdutide demonstrates significant weight loss efficacy and multiple metabolic benefits
Low adherence and increased cost in first year of taking GLP-1a drugs for weight loss
ASA’s Task Force: Stop taking GLP-1 medications for diabetes and weight loss before elective surgery
Journal Watch 11/05/2023
GLP-1 analogues can actually restore anticancer NK immune cells